信息搜索
信息关键字:药
 
『查询2022年信息』  『查询2021年信息』  『查询2020年信息』  『查询2019年信息』  『查询2018年信息』  『查询2017年信息』  『查询2016年信息』
『查询2015年信息』  『查询2014年信息』  『查询2013年信息』  『查询2012年信息』  『查询2011年信息』  『查询2010年信息』  『查询2009年信息』

分页[1] [2] [3] [4] [5] [6] [7] [8] [9] [10] [11] [12] [13] [14] [15] [16] [17] [18] [19] [20] [21] [22] [23] [24] [25] [26] [27] [28] [29] [30] [31] [32] [33] [34] [35] [36] [37] [38] [39] [40] [41] [42] [43] [44] [45] [46] [47] [48] [49] [50] [51] [52] [53] [54] [55] [56] [57] [58] [59] [60] [61] [62] [63] [64] [65] [66] [67] [68] [69] [70] [71] [72] [73] [74] [75] [76] [77] [78] [79] [80] [81] [82] [83] [84] [85] [86] [87] [88] [89] [90] [91] [92] [93] [94] [95] [96] [97] [98] [99] [100] [101] [102] [103] [104] [105] [106] [107] [108] [109] [110] [111] [112] [113] [114] [115] [116] [117] [118] [119] [120] [121] [122] [123] [124] [125] [126] [127] [128] [129] [130] [131] [132] [133] [134] [135] [136] [137] [138] [139] [140] [141] [142] [143] [144] [145] [146] [147] [148] [149] [150] [151] [152] [153] [154] [155] [156] [157] [158] [159] [160] [161] [162] [163] [164] [165] [166] [167] [168] [169] [170] [171] [172] [173] [174] [175] [176] [177] [178] [179] [180] [181] [182] [183] [184] [185] [186] [187] [188] [189] [190] [191] [192] [193] [194] [195] [196] [197] [198] [199] [200] [201] [202] [203] [204] [205] [206] [207] [208] [209] [210] [211] [212] [213] [214] [215] [216] [217] [218] [219] [220] [221] [222] [223] [224] [225] [226] [227] [228] [229] [230] [231] [232] [233] [234] [235] [236] [237] [238] [239]

·金城医药:金城金素三款产品拟中选第八批集采将进一步扩大相关产品销售2023-3-30 12:44:55
·科伦药业多个产品拟中选第八批国家集采有助于提高公司市占率及品牌影响力2023-3-30 11:11:23
·复星医药投59亿研发新品贡献百亿营收大股东套现16亿长短债295亿股价跌60%2023-3-30 10:28:51
·第八批药品国采:规则出现多项重大调整企业理性也不乏“小心思”产品竞价陷分化2023-3-30 9:40:41
·红日药业(300026)3月29日主力资金净卖出3284.85万元2023-3-30 9:34:12
·南新制药(688189)3月29日主力资金净卖出527.69万元2023-3-30 8:47:54
·第八批药品集采开标 多家公司产品拟中标2023-3-30 8:39:38
·“东北药茅”年报出炉!谈集采、市值管理信息量很大!2023-3-30 8:13:41
·平均降价56%第八批药品集采拟中选结果出炉17股获机构密切关注2023-3-30 8:09:48
·平均降价56%,第八批药品集采拟中选结果出炉,17股获机构密切关注2023-3-30 7:56:57
·华世通获得国家药品监督管理局和美国食品药品监督管理局分别核准签发的药物临床试验批准通知书2023-3-30 1:02:28
·首个国产JAK抑制剂上市审评进展顺利泽璟制药新产品商业化可期2023-3-29 22:09:44
·赛升药业2022年净利2.05亿同比下滑49.11%董事长马骉薪酬55.16万2023-3-29 20:49:18
·股票行情快报:沃华医药(002107)3月29日主力资金净卖出381.78万元2023-3-29 20:36:46
·东北制药:2022年净利同比增253.58%拟10派1元2023-3-29 20:11:34
·股票行情快报:国药现代(600420)3月29日主力资金净买入131.26万元2023-3-29 19:18:01
·国药现代:控股子公司收到注射用高纯度尿促性素药品上市申请不予批准通知书2023-3-29 18:39:13
·第八批国家药品集采产生拟中选结果平均降价56%2023-3-29 18:39:04
·灵康药业:丙氨酰谷氨酰胺注射液拟中标第八批全国药品集中采购2023-3-29 17:44:04
·翰宇药业:子公司生长抑素原料获上市申请批准通知书2023-3-29 17:27:04

分页[1] [2] [3] [4] [5] [6] [7] [8] [9] [10] [11] [12] [13] [14] [15] [16] [17] [18] [19] [20] [21] [22] [23] [24] [25] [26] [27] [28] [29] [30] [31] [32] [33] [34] [35] [36] [37] [38] [39] [40] [41] [42] [43] [44] [45] [46] [47] [48] [49] [50] [51] [52] [53] [54] [55] [56] [57] [58] [59] [60] [61] [62] [63] [64] [65] [66] [67] [68] [69] [70] [71] [72] [73] [74] [75] [76] [77] [78] [79] [80] [81] [82] [83] [84] [85] [86] [87] [88] [89] [90] [91] [92] [93] [94] [95] [96] [97] [98] [99] [100] [101] [102] [103] [104] [105] [106] [107] [108] [109] [110] [111] [112] [113] [114] [115] [116] [117] [118] [119] [120] [121] [122] [123] [124] [125] [126] [127] [128] [129] [130] [131] [132] [133] [134] [135] [136] [137] [138] [139] [140] [141] [142] [143] [144] [145] [146] [147] [148] [149] [150] [151] [152] [153] [154] [155] [156] [157] [158] [159] [160] [161] [162] [163] [164] [165] [166] [167] [168] [169] [170] [171] [172] [173] [174] [175] [176] [177] [178] [179] [180] [181] [182] [183] [184] [185] [186] [187] [188] [189] [190] [191] [192] [193] [194] [195] [196] [197] [198] [199] [200] [201] [202] [203] [204] [205] [206] [207] [208] [209] [210] [211] [212] [213] [214] [215] [216] [217] [218] [219] [220] [221] [222] [223] [224] [225] [226] [227] [228] [229] [230] [231] [232] [233] [234] [235] [236] [237] [238] [239]